AKTX — Akari Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Akari Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	14.1	9.36	13.2	3.85	2.6
Prepaid Expenses
Total Other Current Assets
Total Current Assets	14.6	11.6	13.8	4.34	2.95
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	—	—	—	—
Net Goodwill
Net Intangible Assets
Total Assets	14.6	11.6	13.8	4.36	50.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	5.22	6.09	12	4.58	19.9
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	5.22	6.09	12	4.58	28.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.38	5.55	1.79	-0.229	22.2
Total Liabilities & Shareholders' Equity	14.6	11.6	13.8	4.36	50.6
Total Common Shares Outstanding